PharmacoEconomics & Outcomes News Weekly


ISSN: 1173-5503        年代:2003
当前卷期:Volume &NA;  issue 427     [ 查看所有卷期 ]

年代:2003
 
     Volume 421  issue &NA;   
     Volume &NA;  issue 394   
     Volume &NA;  issue 395   
     Volume &NA;  issue 396/397   
     Volume &NA;  issue 398   
     Volume &NA;  issue 399   
     Volume &NA;  issue 400   
     Volume &NA;  issue 401   
     Volume &NA;  issue 402   
     Volume &NA;  issue 403   
     Volume &NA;  issue 404   
     Volume &NA;  issue 405   
     Volume &NA;  issue 406   
     Volume &NA;  issue 407   
     Volume &NA;  issue 408/09   
     Volume &NA;  issue 410   
     Volume &NA;  issue 411   
     Volume &NA;  issue 412   
     Volume &NA;  issue 413   
     Volume &NA;  issue 414   
     Volume &NA;  issue 415   
     Volume &NA;  issue 416   
     Volume &NA;  issue 417   
     Volume &NA;  issue 418   
     Volume &NA;  issue 419   
     Volume &NA;  issue 420   
     Volume &NA;  issue 422   
     Volume &NA;  issue 423   
     Volume &NA;  issue 424   
     Volume &NA;  issue 425   
     Volume &NA;  issue 426   
     Volume &NA;  issue 427
     Volume &NA;  issue 428   
     Volume &NA;  issue 429   
     Volume &NA;  issue 430   
     Volume &NA;  issue 431   
     Volume &NA;  issue 432   
     Volume &NA;  issue 433   
     Volume &NA;  issue 434   
     Volume &NA;  issue 435   
     Volume &NA;  issue 436   
     Volume &NA;  issue 437   
     Volume &NA;  issue 438   
     Volume &NA;  issue 439   
     Volume &NA;  issue 440   
     Volume &NA;  issue 441   
     Volume &NA;  issue 442   
     Volume &NA;  issue 443   
1. Guidelines for the surveillance, alert and management of future outbreaks of SARS*have been released by WHO,
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  427,   2003,   Page  2-2

&NA;,  

Preview

2. Cabergoline warranted for PD in Germany vs levodopa
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  427,   2003,   Page  3-3

&NA;,  

Preview

3. Only 33% of patients receiving cytotoxic chemotherapy for solid tumours received influenza vaccination in a 2001 UK study,
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  427,   2003,   Page  4-4

&NA;,  

Preview

4. Specialty drugs' high costs hidden
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  427,   2003,   Page  5-5

&NA;,  

Preview

5. Reinstitution of cotrimoxazole cost saving for PCP prophylaxis
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  427,   2003,   Page  6-6

&NA;,  

Preview

6. Insulin plus metformin cost saving vs triple therapy in diabetes
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  427,   2003,   Page  7-7

&NA;,  

Preview

7. Rapid defibrillation in public settings warranted?
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  427,   2003,   Page  8-8

&NA;,  

Preview

8. Cardiac care poor for Black vs White women in the US
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  427,   2003,   Page  9-9

&NA;,  

Preview

9. The Italian version of the Fibromyalgia Impact Questionnaire (FIQ) is a"reliable and valid"tool for measuring functional disability among Italian-speaking patients with fibromyalgia,
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  427,   2003,   Page  10-10

&NA;,  

Preview

10. Ex-manufacturer and wholesale prices for reimbursed medicines will be slashed by 20% in Hungary following a decision by the country's government,
  PharmacoEconomics & Outcomes News Weekly,   Volume  &NA;,   Issue  427,   2003,   Page  11-11

&NA;,  

Preview

首页 上一页 下一页 尾页 第1页 共11条